Skip to main content

Advertisement

Log in

Surgical and systemic management of endometrial cancer: an international survey

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To ascertain the spectrum of clinical management of endometrial carcinoma (EC) the largest international survey was conducted to evaluate and identify differences worldwide.

Methods

After validation of a 15-item questionnaire regarding surgical and adjuvant treatment of EC in Germany, an English-adapted questionnaire was put online and posted to all the major gynecological cancer Societies worldwide for further distribution commencing in 2010 and continued for 26 months.

Results

A total of 618 Institutions around the world participated: Central Europe (CE), Southern Europe (SE), Northern Europe (NE), Asia and USA/Canada/UK. Both a therapeutic and staging value was attributed to systematic pelvic and paraaortic lymph node dissection (LND) in CE (74.6 %) and in Asia (67.2 %), as opposed to USA/UK where LND was mainly for staging purposes (53.5 %; p < 0.001). LND was performed up to the renal veins in CE in 86.8 %, in Asia in 80.8 %, in USA/UK in 51.2 % and in SE in 45.1 % (p < 0.001) of cases. In advanced disease, centers from Asia were treated most with adjuvant chemotherapy alone (93.6 %), as opposed to centers in SE, CE and UK/USA that employed combination chemo-radiotherapy in 90.9 % (p < 0.001) of cases. Paclitaxel/carboplatin was mostly used followed by doxorubicin/cisplatin (75 vs. 23.3 %; p < 0.001). In total, 94 % of all participants supported the concept of treating EC patients within appropriate clinical trials.

Conclusions

There is broad range in both the surgical and adjuvant treatment of EC across different countries. Large-scale multicenter prospective trials are warranted to establish consistent, evidence-based guidelines to optimize treatment worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Suppl 6:vi33–vi38. doi:10.1093/annonc/mdt353

    Google Scholar 

  2. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. American College of Obstetricians and Gynecologists (2005). Obstet Gynecol 106(2):413-25

  3. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109(1):11–18

    Article  PubMed Central  PubMed  Google Scholar 

  4. Walsh CS, Karlan BY (2008) Lymphadenectomy’s role in early endometrial cancer: prognostic or therapeutic? J Natl Cancer Inst 100(23):1660–1661

    Article  PubMed  Google Scholar 

  5. Fotopoulou C, Savvatis K, Kraetschell R et al (2010) Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol 149(2):199–203

    Article  PubMed  Google Scholar 

  6. Mariani A, Webb MJ, Keeney GL, Podratz KC (2001) Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81(1):100–104

    Article  CAS  PubMed  Google Scholar 

  7. Marnitz S, Köhler C (2012) Current therapy of patients with endometrial carcinoma. A critical review. Strahlenther Onkol 188(1):12–20

    Article  CAS  PubMed  Google Scholar 

  8. Creutzberg CL, Nout RA (2011) The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep 13(6):472–478

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Kong A, Johnson N, Kitchener HC, Lawrie TA (2012) Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 104(21):1625–1634

    Article  PubMed  Google Scholar 

  10. Kitchener HC, Trimble EL (2009) Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup. Endometrial cancer state of the science meeting. IJGC 19(1):134–140

    Google Scholar 

  11. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83(1):97–112

    Article  PubMed  Google Scholar 

  12. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136

    Article  Google Scholar 

  13. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716

    Article  PubMed  Google Scholar 

  14. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172

    Article  PubMed  Google Scholar 

  15. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S (1997) A clinical and pathologic study on paraaortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82–87

    Article  CAS  PubMed  Google Scholar 

  16. Mariani A, Dowdy SC, Podratz KC (2009) New surgical staging of endometrial cancer: 20 years later. IJGC 105(2):110–111

    Google Scholar 

  17. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA et al (2011) The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol 123(1):58–64

    Article  PubMed  Google Scholar 

  18. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in Endometrial Carcinoma. Lancet 355(9213):1404–1411

    Article  CAS  PubMed  Google Scholar 

  19. Creutzberg CL, van Putten WL, Koper PC et al (2003) PORTEC Study Group. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89(2):201–209

    Article  PubMed  Google Scholar 

  20. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC et al (2004) Postoperative Radiation Therapy in Endometrial Carcinoma Trial. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in Endometrial Carcinoma trial. JCO 22(7):1234–1241

    Article  Google Scholar 

  21. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. JCO 27(21):3547–3556

    Article  Google Scholar 

  22. Nout RA, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM et al (2010) PORTEC Study Group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816–823

    Article  CAS  PubMed  Google Scholar 

  23. Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW et al (2011) Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. JCO 29(13):1692–1700

    Article  Google Scholar 

  24. Nugent EK, Bishop EA, Mathews CA, Moxley KM, Tenney M, Mannel RS et al (2012) Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol 125(1):94–98

    Article  CAS  PubMed  Google Scholar 

  25. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2012) Five-year quality of life of endometrial cancer patients treated in the randomised post operative radiation therapy in endometrial cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer 48(11):1638–1648

    Article  PubMed  Google Scholar 

  26. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56(4):419–427

    CAS  PubMed  Google Scholar 

  27. Kristina Lindemann, Mathias Onsrud, Gunnar Kristensen, Claes Trope (2012) Survival after radiation therapy for early-stage endometrial carcinoma: The Oslo study revisited after up to 43 years of follow-up. JCO 30, suppl; abstr 5008

  28. Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C et al (2012) Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer. Gynecol Oncol 127(2):321–325

    Article  CAS  PubMed  Google Scholar 

  29. Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF et al (2005) A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer. Gynecol Oncol 96(1):198–203

    Article  CAS  PubMed  Google Scholar 

  30. Sehouli J, Lichtenegger W (2004) Management des Endometriumkarzinoms: standards und neue Trends. Der Gynäkologe 37(3):245–256

    Article  Google Scholar 

  31. Creasman WT, Mutch DE, Herzog TJ (2010) ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol 116(3):293–294

    Article  CAS  PubMed  Google Scholar 

  32. Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ (2012) Contemporary management of endometrial cancer. Lancet 379(9823):1352–1360

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the ENGOT society for its support in this survey.

Conflict of interest

No financial or personal conflict of interest by any of the authors to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina Fotopoulou.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 810 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fotopoulou, C., Kraetschell, R., Dowdy, S. et al. Surgical and systemic management of endometrial cancer: an international survey. Arch Gynecol Obstet 291, 897–905 (2015). https://doi.org/10.1007/s00404-014-3510-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3510-3

Keywords

Navigation